Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Arcus Biosciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 148 | 130 | −18 |
| Shares | 44.7M | 45.2M | +430.7K (+1.0%) |
| Value | $1.25B | $1.24B | −$15.0M (−1.2%) |
New holders (14)
Institutions that held Arcus Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 311,796 | $8.56M | 0.03% |
| Park Circle Co | 100,000 | $2.75M | 2.19% |
| Walleye Capital LLC | 86,438 | $2.37M | 0.09% |
| Alpha Paradigm Partners, LLC | 71,951 | $1.98M | 0.75% |
| Dimensional Fund Advisors LP | 34,800 | $956.0K | 0.00% |
| Walleye Trading LLC | 33,479 | $919.0K | 0.02% |
| Blueshift Asset Management, LLC | 25,103 | $689.0K | 0.04% |
| Simplex Trading, LLC | 20,137 | $552.0K | 0.02% |
| Bank Julius Baer & Co. Ltd, Zurich | 19,993 | $549.0K | 0.00% |
| Handelsbanken Fonder AB | 12,300 | $338.0K | 0.00% |
| Wexford Capital LP | 12,000 | $330.0K | 0.05% |
| Martingale Asset Management L P | 11,700 | $322.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 2,315 | $64.0K | 0.00% |
| Tarbox Family Office, Inc. | 1,000 | $27.0K | 0.00% |
Sold out (32)
Institutions that held Arcus Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.